インド市場での競争が激化する中、中国企業は突破口を開くために高障壁の中間製品に注力しています。Facing the price competition from India in the field of generic drug intermediates, Chinese enterprises have turned to high-tech barrier products in search of breakthroughs. For instance, Shengnuo Biotech focuses on GLP-1 weight loss drug intermediat
作成日 09.02